tirzepatide eu approval European Commission grants marketing authorisation for Lilly's Mounjaro® ( tirzepatide), the first GIP and GLP-1 receptor agonist for adults with type 2 diabetes in Europe EU regulator recommends expanding Mounjaro

A consumer adhesive patch offers neither a standardized dose nor a proven path across the skin, which is the entire problem in a single sentence

In addition to the highly publicized weight benefits, these drugs, like semaglutide, have given the magnitude of benefit with a 20-25% reduction in cardiovascular disease events regardless of weight loss achieved. The Viewpoint authors reference a survey published in 2023, which found that while 45% of U.S

Language development is frequently affected, encompassing delayed acquisition and severe impairments in expressive abilities

Antioxidant support for skin clarity As an antioxidant, glutathione helps reduce the impact of environmental stressors such as pollution and UV exposure, which are known to contribute to pigmentation concerns